REGISTERED NUMBER: SC840388 (Scotland)

Unaudited Financial Statements

for the Period 6 March 2025 to 31 March 2026

for

Glasgow Implant Lab Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

C McMahon

REGISTERED OFFICE:

48 West George Street

Glasgow

G2 1BP

REGISTERED NUMBER:

SC840388 (Scotland)

ACCOUNTANTS:

Greg Hannah Ltd

Chartered Accountants

29 Brandon Street

Hamilton

ML3 6DA

CURRENT ASSETS

Debtors

5

28,889

Cash at bank

541

29,430

CREDITORS

Amounts falling due within one year

6

19,434

NET CURRENT ASSETS

9,996

TOTAL ASSETS LESS CURRENT LIABILITIES

9,996

CAPITAL AND RESERVES

Called up share capital

1

Retained earnings

9,995

9,996

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 October 2026 and were signed by:

C McMahon - Director

1.	STATUTORY INFORMATION

Glasgow Implant Lab Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. There were no material departures from that standard.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is derived from dental instruments supplied by the company.

Turnover is measured at the fair value of the services supplied, net of discounts and is recognised at the point that the company obtains the right to consideration.

Taxation

Taxation for the period comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Trade debtors

22,122

Other debtors

6,767

28,889

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Trade creditors

521

Taxation and social security

17,945

Other creditors

968

19,434

7.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31 March 2026:

£

C McMahon

Balance outstanding at start of period

-

Amounts advanced

56,767

Amounts repaid

(50,000

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of period

6,767

Interest is charged on any amounts owed to the company by the director and there are no fixed repayment terms. The above loan was repaid in full within nine months of the year end.